• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽作为紧密连接调节剂。

Peptides as tight junction modulators.

机构信息

Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan.

出版信息

Curr Pharm Des. 2011;17(25):2699-703. doi: 10.2174/138161211797416084.

DOI:10.2174/138161211797416084
PMID:21728977
Abstract

The first step in drug absorption is the passage of drug molecules across epithelial cell sheets. Epithelial cell sheets are pivotal for the maintenance of homeostasis in the body by acting as a biological barrier that separates the inside of the body from the outside environment. Intercellular space between the adjacent epithelial cells is tightly sealed by tight junctions (TJs), which prevent solutes from freely moving across the epithelial cell sheets. Modulation of the TJ barrier has been a potent strategy for drug absorption. Absorption enhancers have been investigated since the 1980s, and sodium caprate is clinically used as an absorption enhancer. However, the biochemical constituents and structures of TJs were not elucidated until 1993. Occludin, a tetra-transmembrane protein, was identified to be a structural component of TJs in 1993. Claudin, another tetra-transmembrane protein, was identified as a structural and functional component of TJs in 1998. Modulation of occludin- or claudin-barrier is novel methods to enhance drug absorption. Recently, synthetic TJ-binding peptides, a kinase of claudin and peptide fragments of toxins have been developed. In the present review, we summarize the recent progress in TJ-modulating peptides and discuss their potencies.

摘要

药物吸收的第一步是药物分子穿过上皮细胞层。上皮细胞层通过充当将体内与外部环境分开的生物屏障,对于维持体内平衡至关重要。相邻上皮细胞之间的细胞间隙由紧密连接(TJ)紧密密封,防止溶质自由穿过上皮细胞层。调节 TJ 屏障已成为药物吸收的有效策略。自 20 世纪 80 年代以来,一直在研究吸收增强剂,并且辛酸纳已在临床上用作吸收增强剂。但是,直到 1993 年才阐明 TJ 的生化成分和结构。1993 年发现封闭蛋白是 TJ 的结构组成部分,这是一种四跨膜蛋白。 Claudin 是另一种四跨膜蛋白,于 1998 年被鉴定为 TJ 的结构和功能组成部分。调节封闭蛋白或紧密连接蛋白屏障是增强药物吸收的新方法。最近,已经开发出了合成 TJ 结合肽,claudin 的激酶和毒素的肽片段。在本综述中,我们总结了 TJ 调节肽的最新进展,并讨论了它们的效力。

相似文献

1
Peptides as tight junction modulators.肽作为紧密连接调节剂。
Curr Pharm Des. 2011;17(25):2699-703. doi: 10.2174/138161211797416084.
2
Spiral progression in the development of absorption enhancers based on the biology of tight junctions.基于紧密连接生物学的吸收增强剂的螺旋式发展。
Adv Drug Deliv Rev. 2012 May 1;64(6):515-22. doi: 10.1016/j.addr.2011.07.004. Epub 2011 Jul 23.
3
A key claudin extracellular loop domain is critical for epithelial barrier integrity.关键的紧密连接蛋白细胞外环结构域对上皮屏障完整性至关重要。
Am J Pathol. 2008 Apr;172(4):905-15. doi: 10.2353/ajpath.2008.070698. Epub 2008 Mar 18.
4
Tight junction modulators: promising candidates for drug delivery.紧密连接调节剂:药物递送的有前景候选物。
Curr Med Chem. 2007;14(23):2482-8. doi: 10.2174/092986707782023640.
5
Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.利用 Claudin 结合物和 Angubindin-1 开发紧密连接蛋白导向药物的潜力。
Int J Mol Sci. 2019 Aug 17;20(16):4016. doi: 10.3390/ijms20164016.
6
Claudin as a target for drug development.Claudin 作为药物研发的靶点。
Curr Med Chem. 2011;18(12):1861-5. doi: 10.2174/092986711795496809.
7
A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells.在上皮细胞的细胞间移动过程中,紧密连接特异性黏附分子claudins出现了一种特殊的内化现象。
J Cell Sci. 2004 Mar 1;117(Pt 7):1247-57. doi: 10.1242/jcs.00972.
8
Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.产气荚膜梭菌肠毒素 C 端突变片段对紧密连接蛋白 4 的亲和力增加,并在体外可逆调节紧密连接。
Biochem Biophys Res Commun. 2011 Jul 8;410(3):466-70. doi: 10.1016/j.bbrc.2011.05.161. Epub 2011 Jun 6.
9
The Claudins: From Tight Junctions to Biological Systems.紧密连接蛋白 Claudin:从紧密连接到生物系统。
Trends Biochem Sci. 2019 Feb;44(2):141-152. doi: 10.1016/j.tibs.2018.09.008. Epub 2018 Oct 25.
10
[Non-invasive drug delivery system with the claudin binder].具有紧密连接蛋白结合剂的非侵入性给药系统
Yakugaku Zasshi. 2011;131(11):1583-7. doi: 10.1248/yakushi.131.1583.

引用本文的文献

1
Role of linc00174/miR-138-5p (miR-150-5p)/FOSL2 Feedback Loop on Regulating the Blood-Tumor Barrier Permeability.长链非编码RNA00174/微小RNA-138-5p(微小RNA-150-5p)/FOS样抗原2反馈环在调节血肿瘤屏障通透性中的作用
Mol Ther Nucleic Acids. 2019 Dec 6;18:1072-1090. doi: 10.1016/j.omtn.2019.10.031. Epub 2019 Nov 9.
2
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.应对卵巢癌腹水挑战:治疗和研究的新途径。
Nat Rev Cancer. 2013 Apr;13(4):273-82. doi: 10.1038/nrc3432. Epub 2013 Feb 21.
3
Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.
作为跨上皮药物输送装置的纳米线涂覆微颗粒的设计中的形状效应。
ACS Nano. 2012 Sep 25;6(9):7832-41. doi: 10.1021/nn3019865. Epub 2012 Aug 24.